InsidersTradesSigma
Follow the Genovis A/B stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Genovis A/B has recorded 0 insider filings. Market capitalisation: €1.3bn. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Genovis A/B is a company focused on developing enzymatic solutions for research and the biopharmaceutical industry. It is listed on the Stockholm Stock Exchange (XSTO).